Double maintains 1 strategies that include AZN - AstraZeneca PLC
Current Value
$74.001 Year Return
Current Value
$74.001 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NVS | 48.36% | $211.54B | +16.28% | 3.44% |
SNY | 39.34% | $135.77B | +14.85% | 3.67% |
GSK | 39.22% | $78.79B | -8.68% | 4.01% |
UL | 36.31% | $149.25B | +19.46% | 3.14% |
NEM | 31.09% | $54.42B | +32.53% | 2.05% |
BUD | 31.04% | $107.94B | +0.75% | 1.43% |
LLY | 30.48% | $782.95B | +8.59% | 0.66% |
GMAB | 29.84% | $12.44B | -35.32% | 0.00% |
TAK | 29.42% | $47.14B | +8.78% | 2.17% |
RACE | 29.30% | $76.61B | -0.90% | 0.60% |
O | 28.80% | $51.73B | +8.51% | 4.98% |
CE | 27.98% | $6.34B | -66.83% | 3.77% |
CCEP | 26.79% | $40.10B | +25.60% | 2.40% |
BFAM | 26.54% | $7.29B | +12.93% | 0.00% |
LOAR | 26.49% | $6.61B | +152.32% | 0.00% |
AMT | 26.49% | $101.72B | +12.74% | 2.94% |
ECL | 26.24% | $71.91B | +11.23% | 0.97% |
NEE | 26.09% | $145.82B | +11.85% | 2.97% |
AWK | 26.03% | $28.76B | +22.63% | 2.08% |
CCU | 25.95% | $2.81B | +26.25% | 2.78% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ARIS | -22.12% | $992.33M | +126.91% | 1.43% |
HCKT | -20.57% | $807.85M | +20.84% | 1.55% |
AMSF | -19.69% | $1.00B | +12.91% | 2.84% |
LIND | -19.06% | $506.02M | +2.77% | 0.00% |
WTTR | -17.75% | $1.09B | +13.64% | 2.49% |
VMEO | -17.52% | $867.12M | +31.50% | 0.00% |
RES | -15.61% | $1.19B | -29.58% | 2.91% |
QUAD | -14.75% | $285.30M | +0.55% | 4.14% |
GOGO | -14.21% | $1.13B | +2.62% | 0.00% |
QLYS | -14.18% | $4.59B | -24.72% | 0.00% |
EIG | -13.92% | $1.23B | +13.11% | 2.37% |
PIPR | -13.54% | $4.39B | +26.94% | 1.03% |
ALSN | -13.37% | $8.18B | +18.36% | 1.07% |
CABO | -13.36% | $1.50B | -37.01% | 4.41% |
ALAB | -13.31% | $9.68B | -16.10% | 0.00% |
DXPE | -12.87% | $1.29B | +53.16% | 0.00% |
EPAC | -12.86% | $2.43B | +26.37% | 0.09% |
SKWD | -12.81% | $2.13B | +41.99% | 0.00% |
MC | -12.76% | $4.12B | +3.90% | 4.21% |
HPK | -12.54% | $1.60B | -19.87% | 1.27% |
SeekingAlpha
During the fourth quarter of 2024, Impax International Sustainable Economy Fund underperformed the MSCI EAFE benchmark. Read more here.
Yahoo
The FDA approves AZN's sBLA seeking the expanded use of Imfinzi for adult patients with muscle-invasive bladder cancer.
Yahoo
The company reported results from the Phase IIb PURSUIT trial at ACC 2025.
Yahoo
The latest investor updates on stocks that are trending on Tuesday.
Yahoo
The decision follows a priority review and is based on data from the Phase III NIAGARA trial.
SeekingAlpha
European equities, via the SPEU ETF, outshine U.S. equities this year with better value, higher yields, and diversified sector exposure. See more here.
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SGOV | -0.06% | $39.39B | 0.09% |
MAGS | -0.07% | $1.72B | 0.29% |
IAT | 0.08% | $706.05M | 0.4% |
IBDQ | -0.09% | $3.18B | 0.1% |
XLC | 0.10% | $20.14B | 0.09% |
VOX | -0.11% | $4.37B | 0.09% |
BCI | -0.22% | $1.43B | 0.26% |
FCOM | 0.24% | $1.37B | 0.084% |
CLSE | -0.24% | $167.58M | 1.55% |
KBE | -0.33% | $1.94B | 0.35% |
AMLP | 0.36% | $10.87B | 0.85% |
AIRR | 0.37% | $3.12B | 0.7% |
CORN | -0.43% | $51.34M | 0.2% |
KBWB | 0.54% | $3.69B | 0.35% |
CRPT | -0.59% | $75.13M | 0.85% |
MLPX | -0.63% | $2.77B | 0.45% |
EZBC | 0.64% | $414.51M | 0.29% |
FBTC | 0.66% | $16.48B | 0.25% |
GCC | -0.71% | $148.21M | 0.55% |
BITB | 0.72% | $3.20B | 0.2% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PPH | 53.35% | $664.88M | 0.36% |
IXJ | 45.02% | $3.93B | 0.41% |
EWL | 43.21% | $1.14B | 0.5% |
EWU | 43.19% | $3.25B | 0.5% |
FLGB | 41.08% | $720.50M | 0.09% |
IDHQ | 37.56% | $365.54M | 0.29% |
EFAV | 37.15% | $4.71B | 0.2% |
BBEU | 36.57% | $4.16B | 0.09% |
IEV | 36.33% | $1.97B | 0.61% |
SPEU | 36.08% | $1.08B | 0.07% |
DBEU | 35.81% | $660.46M | 0.45% |
QEFA | 35.73% | $883.02M | 0.3% |
VGK | 35.13% | $21.96B | 0.06% |
IEUR | 35.11% | $5.43B | 0.09% |
IHE | 34.69% | $600.56M | 0.39% |
KXI | 34.35% | $717.10M | 0.41% |
IYH | 34.35% | $3.18B | 0.39% |
IQLT | 34.30% | $8.92B | 0.3% |
HDEF | 33.90% | $1.85B | 0.09% |
IQDG | 33.89% | $762.81M | 0.42% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -19.28% | $195.31M | 0.85% |
UUP | -17.13% | $327.80M | 0.77% |
USDU | -15.97% | $213.46M | 0.5% |
DBE | -13.30% | $54.58M | 0.77% |
TPMN | -12.99% | $33.51M | 0.65% |
DBA | -12.87% | $822.16M | 0.93% |
CLOI | -12.48% | $1.02B | 0.4% |
DBO | -11.76% | $197.54M | 0.77% |
UGA | -11.55% | $88.11M | 0.97% |
EQLS | -11.42% | $4.77M | 1% |
USL | -10.95% | $46.60M | 0.85% |
USO | -9.97% | $1.02B | 0.6% |
BNO | -9.52% | $95.40M | 1% |
OILK | -9.37% | $66.42M | 0.69% |
COMT | -8.54% | $674.22M | 0.48% |
TAIL | -8.50% | $86.92M | 0.59% |
USCI | -8.30% | $236.09M | 1.07% |
PSCE | -8.04% | $68.67M | 0.29% |
GSG | -7.82% | $1.04B | 0.75% |
DBC | -7.77% | $1.32B | 0.87% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUBS | -0.01% | $29.79B | -10.29% | 0.00% |
WTW | 0.01% | $33.69B | +23.59% | 1.05% |
NEO | 0.02% | $1.22B | -38.34% | 0.00% |
EVRI | 0.02% | $1.18B | +34.68% | 0.00% |
AAON | -0.02% | $6.38B | -11.20% | 0.44% |
CNO | -0.03% | $4.18B | +53.13% | 1.55% |
FATBB | -0.04% | $48.04M | -31.13% | 15.56% |
E | -0.04% | $47.07B | -2.86% | 6.76% |
TDS | -0.04% | $4.42B | +147.22% | 0.41% |
LFCR | -0.05% | $260.66M | +21.59% | 0.00% |
PEGA | 0.06% | $5.97B | +10.97% | 0.13% |
WRBY | 0.07% | $2.20B | +30.21% | 0.00% |
SNA | -0.08% | $17.67B | +14.38% | 2.39% |
WAFD | 0.08% | $2.33B | +0.70% | 3.70% |
CRWD | -0.08% | $87.40B | +10.32% | 0.00% |
WDFC | 0.08% | $3.31B | -1.97% | 1.48% |
KKR | 0.08% | $102.69B | +15.61% | 0.60% |
CF | 0.08% | $13.01B | -6.22% | 2.55% |
KODK | -0.08% | $509.39M | +30.31% | 0.00% |
NPO | -0.09% | $3.40B | -1.97% | 0.75% |